RIL
RLAY icon

Rothschild Investment LLC’s Relay Therapeutics RLAY Stock Holding History

Rothschild Investment LLC’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Hold
540
– – ﹤0.01% 1871
2026
Q1 		$5.37K Buy
540
+71
+15% +$635 ﹤0.01% 2017
2025
Q4 		$3.97K Buy
469
+9
+2% +$64 ﹤0.01% 2012
2025
Q3 		$2.4K Sell
460
-75
-14% -$286 ﹤0.01% 2111
2025
Q2 		$1.85K Buy
535
+325
+155% +$967 ﹤0.01% 2136
2025
Q1 		$550 Buy
210
+90
+75% +$353 ﹤0.01% 2592
2024
Q4 		$494 Sell
120
-15
-11% -$82 ﹤0.01% 2536
2024
Q3 		$956 Buy
135
+75
+125% +$560 ﹤0.01% 2202
2024
Q2 		$391 Buy
60
+45
+300% +$307 ﹤0.01% 2168
2024
Q1 		$125 Buy
+15
New +$146 ﹤0.01% 2068

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's RLAY Position: Q2 2026 in Review

Rothschild Investment LLC held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 540 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1871.

Rothschild Investment LLC first reported a position in RLAY in Q1 2024 and has held it in 10 quarters since. 241 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Rothschild Investment LLC held 540 shares of Relay Therapeutics worth $10.1K as of Q2 2026.
  • Rothschild Investment LLC left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1871 holding.
  • Rothschild Investment LLC first reported a position in Relay Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 241 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.